Pharmacological modulation of SK3 channels

This publication has 16 references indexed in Scilit:

• Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia
  Neuroscience Letters, 2000
• Pharmacological characterization of small‐conductance Ca²⁺‐activated K⁺ channels stably expressed in HEK 293 cells
  British Journal of Pharmacology, 2000
• The pharmacology of hSK1 Ca²⁺‐activated K⁺ channels expressed in mammalian cell lines
  British Journal of Pharmacology, 2000
• Activation of the human intermediate-conductance Ca2+-activated K+ channel by 1-ethyl-2-benzimidazolinone is strongly Ca2+-dependent
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1999
• Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping
  The Journal of Thoracic and Cardiovascular Surgery, 1999
• Stable expression of the human large‐conductance Ca²⁺‐activated K⁺ channel α‐ and β‐subunits in HEK293 cells
  FEBS Letters, 1997
• The pharmacology and mechanism of action of riluzole
  Neurology, 1996
• Small-Conductance, Calcium-Activated Potassium Channels from Mammalian Brain
  Science, 1996
• A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
  New England Journal of Medicine, 1994
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre
  Pflügers Archiv - European Journal of Physiology, 1991